Publication: Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5years old in Malawi: A protocol for a cluster randomized trial
Issued Date
2018-07-20
Resource Type
ISSN
14712431
Other identifier(s)
2-s2.0-85050270662
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
BMC Pediatrics. Vol.18, No.1 (2018)
Suggested Citation
Thandile Gondwe, Bjarne Robberstad, Mavuto Mukaka, Siri Lange, Bjørn Blomberg, Kamija Phiri Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5years old in Malawi: A protocol for a cluster randomized trial. BMC Pediatrics. Vol.18, No.1 (2018). doi:10.1186/s12887-018-1199-3 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/46499
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Delivery strategies for malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5years old in Malawi: A protocol for a cluster randomized trial
Abstract
© 2018 The Author(s). Background: Children initially hospitalized with severe anaemia in Africa are at high risk of readmission or death within 6months after discharge. No intervention strategy specifically protects children during the post-discharge period. Recent evidence from Malawi shows that 3months of post-discharge malaria chemoprevention (PMC) with monthly treatment with artemether-lumefantrine in children with severe malarial anaemia prevented 31% of deaths and readmissions. While a confirmatory multi-centre trial for PMC with dihydroartemisinin-piperaquine is on going in Kenya and Uganda, there is a need to design and evaluate an effective delivery strategy for this promising intervention. Methods: This is a cluster-randomized trial with 5 arms, each representing a unique PMC delivery strategy. Convalescent children aged less than 5years and weighing more than 5kg admitted with severe anaemia and clinically stable are included. All eligible children will receive dihydroartemisinin-piperaquine at 2, 6 and 10weeks after discharge either: 1) in the community without an SMS reminder; 2) in the community with an SMS reminder; 3) in the community with a community health worker reminder; 4) at the hospital with an SMS reminder; or 5) at the hospital without an SMS reminder. For community-based strategies (1, 2 and 3), mothers will be given all the PMC doses at the time of discharge while for hospital-based strategies (4 and 5) mothers will be required to visit the hospital each month. Each arm will consist of 25 clusters with an average of 3 children per cluster giving approximately 75 children and will be followed up for 15weeks. The primary outcome measure is uptake of complete courses of PMC drugs. Discussion: The proposed study will help to identify the most effective, cost-effective, acceptable and feasible strategy for delivering malaria chemoprevention for post-discharge management of severe anaemia in under-five children in the Malawian context. This information is important for policy decision in the quest for new strategies for malaria control in children in similar contexts.